ArticleBMC gastroenterology2026

Recurrence‑related factors after discontinuation of adjuvant imatinib in intermediate‑ and high‑risk GIST: a retrospective cohort study.

Yibo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.